R. Carruthers
Director of Finance/CFO at EDGEWISE THERAPEUTICS, INC.
Net worth: 561 566 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kevin Koch | M | 63 | 23 years | |
| Anthony D. Piscopio | M | - |
OnKure, Inc.
 OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | 22 years |
| Robert Conway | M | 70 |
ClinOne, Inc.
 ClinOne, Inc. Packaged SoftwareTechnology Services ClinOne, Inc. develops mobile software application. The firm serves for sites and patients. It offers elaerning, screening, documents, videos, econsent, procedure manager, and adverse events services. The company was founded by Rob Bohacs and Eric Schraufnagel and is headquartered in Denver, CO. | 21 years |
| John Moore | M | 59 |
Nivalis Therapeutics, Inc.
 Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 20 years |
| Xuedong Liu | M | - |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | 13 years |
| Joseph Ferra | M | 48 | 3 years | |
| Aaron Fox-Collis | M | - | 4 years | |
| Peter Thompson | M | 64 | 7 years | |
| Steven Elms | M | 60 | 5 years | |
| Alan Russell | M | 54 | 7 years | |
| Nicholas A. Saccomano | M | 65 |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | 6 years |
| Badreddin Edris | M | 37 | 7 years | |
| Jon Root | M | 64 | 5 years | |
| Tammy Furlong | F | 53 | - | |
| Andrew Phillips | M | 53 |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | 4 years |
| Darcy Mootz | M | 50 | - | |
| Jonathan Fox | M | 66 | 1 years | |
| Maurice A. Gaubatz | M | - |
Pyxant Labs, Inc.
 Pyxant Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Pyxant Labs, Inc. provides bio analytical development services. It offers metabolism and toxicology bio analytical support, pharmaceutical & bioequivalence support, impurities characterization, fingerprinting and isolation, storage stability for formulations and biological matrices and formulations development analytical support services. The company was founded by Maurice A. Gaubatz in 2000 and is headquartered in Colorado Springs, CO. | 24 years |
| Timothy Clackson | M | 58 | 4 years | |
| Laura Brege | F | 66 | 4 years | |
| Candice Masse | F | - | - | |
| Joanne Donovan | M | 67 | 3 years | |
| Marc Semigran | M | 67 | 2 years | |
| Isaac Manke | M | 47 |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | 3 years |
| Jerrod Langley | M | - |
Pyxant Labs, Inc.
Pyxant Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Pyxant Labs, Inc. provides bio analytical development services. It offers metabolism and toxicology bio analytical support, pharmaceutical & bioequivalence support, impurities characterization, fingerprinting and isolation, storage stability for formulations and biological matrices and formulations development analytical support services. The company was founded by Maurice A. Gaubatz in 2000 and is headquartered in Colorado Springs, CO. | 18 years |
| Guobao Zhao | M | - |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | 7 years |
| David Dornan | M | 46 | 2 years | |
| Behrad Derakhshan | M | 44 | 4 years | |
| Leslie Leinwand | M | - | - | |
| Valerie Jansen | M | 46 | - | |
| Kimberly Milazzo | F | - |
Pyxant Labs, Inc.
Pyxant Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Pyxant Labs, Inc. provides bio analytical development services. It offers metabolism and toxicology bio analytical support, pharmaceutical & bioequivalence support, impurities characterization, fingerprinting and isolation, storage stability for formulations and biological matrices and formulations development analytical support services. The company was founded by Maurice A. Gaubatz in 2000 and is headquartered in Colorado Springs, CO. | 18 years |
| Robert Yang | M | - | - | |
| John DeMattei | M | - |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Shawn Leland | M | 40 | 4 years | |
| Jon Congleton | M | 60 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 3 years |
| James Rickey | M | 45 | 7 years | |
| Robert G. Kuhbach | M | 76 | 16 years | |
| Jay Venkatesan | M | 52 | 5 years | |
| Paul Sekhri | M | 66 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 1 years |
| Liam Ratcliffe | M | 60 | 2 years | |
| Gil van Lunsen | M | 81 | 17 years | |
| Cynthia Smith | F | 55 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 1 years |
| Evan Loh | M | 65 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 5 years |
| Charles Baum | M | 65 | 5 years | |
| Andrew Robbins | M | 48 | 7 years | |
| Lori Hu | F | 38 | 5 years | |
| Stanford Peng | M | 53 | 7 years | |
| John Robinson | M | 50 | - | |
| David McAvoy | M | 62 | 4 years | |
| Kenneth Harrison | M | 44 | 4 years | |
| Colin Walsh | M | 38 | 4 years | |
| Gwen A. Fyfe | M | 72 | 7 years | |
| Robert Brown | M | 62 | 4 years | |
| Ron Squarer | M | 57 | 7 years | |
| Thomas L. Reece | M | 81 | 15 years | |
| Mitchell Gold | M | 57 | 7 years | |
| Francis J. Bullock | M | 87 | 14 years | |
| John L. Zabriskie | M | 85 | 12 years | |
| John Orwin | M | 59 | 7 years | |
| William Spurgeon | M | 65 | 26 years | |
| Robert W. Overell | M | 69 | 4 years | |
| Mark R. Miglarese | M | - | 2 years | |
| Amy C. Cavers | F | - | - | |
| David Rodman | M | 69 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 1 years |
| Sanjeev Ahuja | M | - | 1 years | |
| Adam Levy | M | 46 | - | |
| Thaedra Thullberry | F | - | 7 years | |
| Marvin H. Caruthers | M | 84 | 13 years | |
| David J. Horin | M | 56 | - | |
| Jonathan Leff | M | 55 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 2 years |
| Richard Gaster | M | 40 | 2 years | |
| Eli M. Wallace | M | 57 | 11 years | |
| Brad Barnett | M | - | 19 years | |
| Sahil Chopra | M | - | 1 years | |
| John Yates | M | 67 | 1 years | |
| Nicolas Gilmour | M | - |
Pyxant Labs, Inc.
Pyxant Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Pyxant Labs, Inc. provides bio analytical development services. It offers metabolism and toxicology bio analytical support, pharmaceutical & bioequivalence support, impurities characterization, fingerprinting and isolation, storage stability for formulations and biological matrices and formulations development analytical support services. The company was founded by Maurice A. Gaubatz in 2000 and is headquartered in Colorado Springs, CO. | - |
| Victor Sandor | M | 57 | 5 years | |
| William D. Ju | M | 67 | 6 years | |
| Gary M. Clark | M | - | - | |
| John Josey | M | 63 | 13 years | |
| James D. Winkler | M | - | - | |
| David A. Robaugh | M | - |
Pyxant Labs, Inc.
Pyxant Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Pyxant Labs, Inc. provides bio analytical development services. It offers metabolism and toxicology bio analytical support, pharmaceutical & bioequivalence support, impurities characterization, fingerprinting and isolation, storage stability for formulations and biological matrices and formulations development analytical support services. The company was founded by Maurice A. Gaubatz in 2000 and is headquartered in Colorado Springs, CO. | - |
| Bengt Bergstrom | M | - | - | |
| Janice Troha | F | - | - | |
| Tom Sokolowski | M | - |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | - |
| Frank Pallas | M | - |
Pyxant Labs, Inc.
Pyxant Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Pyxant Labs, Inc. provides bio analytical development services. It offers metabolism and toxicology bio analytical support, pharmaceutical & bioequivalence support, impurities characterization, fingerprinting and isolation, storage stability for formulations and biological matrices and formulations development analytical support services. The company was founded by Maurice A. Gaubatz in 2000 and is headquartered in Colorado Springs, CO. | - |
| Howard T. Holden | M | - | - | |
| Karsten Witt | M | 68 | 2 years | |
| Robert E. Winkler | M | 58 | - | |
| Douglas Williams | M | 66 | 7 years | |
| George Abercrombie | M | 69 | 10 years | |
| Michael N. Needle | M | 64 | 1 years | |
| Melissa Gaubatz | F | - |
Pyxant Labs, Inc.
Pyxant Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Pyxant Labs, Inc. provides bio analytical development services. It offers metabolism and toxicology bio analytical support, pharmaceutical & bioequivalence support, impurities characterization, fingerprinting and isolation, storage stability for formulations and biological matrices and formulations development analytical support services. The company was founded by Maurice A. Gaubatz in 2000 and is headquartered in Colorado Springs, CO. | - |
| Patrice Lee | M | - | - | |
| Julie VanOrsdel Daves | F | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 95 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- R. Carruthers
- Personal Network
